Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Mechanical Postconditioning Promotes Glucose Metabolism and AMPK Activity in Parallel with Improved Post-Ischemic Recovery in an Isolated Rat Heart Model of Donation after Circulatory Death.

Tytuł:
Mechanical Postconditioning Promotes Glucose Metabolism and AMPK Activity in Parallel with Improved Post-Ischemic Recovery in an Isolated Rat Heart Model of Donation after Circulatory Death.
Autorzy:
Arnold M; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Méndez-Carmona N; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Gulac P; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, 832 32 Bratislava 3, Slovakia.
Wyss RK; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Rutishauser N; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Segiser A; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Carrel T; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Longnus S; Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Jan 31; Vol. 21 (3). Date of Electronic Publication: 2020 Jan 31.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Death*
Transplantation Conditioning*
AMP-Activated Protein Kinases/*metabolism
Glucose/*metabolism
Heart Transplantation/*methods
Reperfusion Injury/*prevention & control
Tissue Donors/*supply & distribution
Animals ; Male ; Models, Animal ; Rats ; Rats, Wistar
References:
Am J Pathol. 2000 Jun;156(6):2111-21. (PMID: 10854232)
Circ Res. 2008 Jan 4;102(1):131-5. (PMID: 17967780)
Trends Cell Biol. 2016 Mar;26(3):190-201. (PMID: 26616193)
J Mol Cell Cardiol. 2009 May;46(5):607-9. (PMID: 19318238)
J Am Coll Cardiol. 2019 Apr 2;73(12):1447-1459. (PMID: 30922476)
Circ Res. 2017 Apr 28;120(9):1477-1486. (PMID: 28450365)
N Engl J Med. 2007 Sep 13;357(11):1121-35. (PMID: 17855673)
Cardiovasc Res. 2017 May 1;113(6):564-585. (PMID: 28453734)
Eur Heart J. 2012 Jul;33(14):1787-847. (PMID: 22611136)
Clin Sci (Lond). 2015 Mar;128(6):349-55. (PMID: 25456320)
Heart Fail Rev. 2011 Jan;16(1):49-69. (PMID: 20571888)
Biochim Biophys Acta. 2013 Apr;1833(4):848-56. (PMID: 22967513)
Int J Biochem Cell Biol. 2006 Mar;38(3):414-9. (PMID: 16280253)
Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2123-34. (PMID: 21421816)
Int J Obes (Lond). 2008 Sep;32 Suppl 4:S29-35. (PMID: 18719595)
J Pharmacol Toxicol Methods. 2000 Mar-Apr;43(2):141-52. (PMID: 11150742)
Cell Physiol Biochem. 2008;22(5-6):635-44. (PMID: 19088445)
Biochim Biophys Acta. 2014 Aug;1837(8):1350-61. (PMID: 24704335)
Eur J Cardiothorac Surg. 2016 Jan;49(1):1-4. (PMID: 26487100)
Heart Surg Forum. 2010 Feb;13(1):E52-6. (PMID: 20150042)
J Biol Chem. 2005 Nov 11;280(45):37803-13. (PMID: 16154996)
Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H579-88. (PMID: 12860564)
Mol Cell. 2008 Apr 25;30(2):214-26. (PMID: 18439900)
Circ Res. 2004 Aug 6;95(3):230-2. (PMID: 15242972)
J Physiol Sci. 2012 Jul;62(4):333-41. (PMID: 22614393)
Eur J Cardiothorac Surg. 2016 Jan;49(1):32-9. (PMID: 25694472)
J Physiol. 2006 Jul 1;574(Pt 1):95-112. (PMID: 16690706)
World J Cardiol. 2011 Jun 26;3(6):186-200. (PMID: 21772945)
Transplantation. 2016 Dec;100(12):2621-2629. (PMID: 27861290)
J Surg Res. 2010 Dec;164(2):175-81. (PMID: 20934717)
Acta Anaesthesiol Scand. 2012 Jan;56(1):48-56. (PMID: 22103673)
J Mol Cell Cardiol. 2012 Jan;52(1):48-61. (PMID: 21964191)
Circ Res. 1995 Jul;77(1):88-97. (PMID: 7788886)
Cardiovasc Res. 2009 Oct 1;84(1):42-53. (PMID: 19477967)
Cardiovasc Drugs Ther. 2008 Oct;22(5):391-7. (PMID: 18563544)
Cardiovasc Res. 2009 Nov 1;84(2):201-8. (PMID: 19666677)
Crit Rev Biochem Mol Biol. 2010 Aug;45(4):276-95. (PMID: 20522000)
Physiol Rev. 2005 Jul;85(3):1093-129. (PMID: 15987803)
Shock. 2008 Jun;29(6):761-8. (PMID: 18496137)
J Heart Lung Transplant. 2019 Jun;38(6):647-657. (PMID: 30655178)
Front Physiol. 2016 Nov 22;7:543. (PMID: 27920725)
Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R936-44. (PMID: 12626360)
Lancet. 2015 Jun 27;385(9987):2585-91. (PMID: 25888085)
Cardiovasc Res. 2004 Apr 1;62(1):74-85. (PMID: 15023554)
J Heart Lung Transplant. 2017 Dec;36(12):1311-1318. (PMID: 29173394)
J Am Coll Cardiol. 2002 Feb 20;39(4):718-25. (PMID: 11849874)
Curr Opin Organ Transplant. 2017 Jun;22(3):251-259. (PMID: 28426448)
Cardiovasc Res. 2010 Aug 1;87(3):406-23. (PMID: 20448097)
Am J Transplant. 2019 Feb;19(2):331-344. (PMID: 30019521)
Am J Transplant. 2016 Mar;16(3):783-93. (PMID: 26663659)
Trends Endocrinol Metab. 2017 Aug;28(8):545-560. (PMID: 28647324)
Lancet. 2019 Oct 19;394(10207):1415-1424. (PMID: 31500849)
J Heart Lung Transplant. 2019 Jul;38(7):767-777. (PMID: 30952549)
Metabolism. 2017 Jun;71:107-117. (PMID: 28521863)
J Clin Invest. 2004 Jun;113(11):1535-49. (PMID: 15173880)
J Heart Lung Transplant. 2016 Oct;35(10):1255-1260. (PMID: 27498383)
Grant Information:
310030149730/1 Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Contributed Indexing:
Keywords: cardiac ischemia reperfusion injury; contractile function; donation after circulatory death; glucose metabolism; postconditioning
Substance Nomenclature:
EC 2.7.11.31 (AMP-Activated Protein Kinases)
IY9XDZ35W2 (Glucose)
Entry Date(s):
Date Created: 20200207 Date Completed: 20201117 Latest Revision: 20201117
Update Code:
20240105
PubMed Central ID:
PMC7039237
DOI:
10.3390/ijms21030964
PMID:
32024002
Czasopismo naukowe
Donation after circulatory death (DCD) could improve donor heart availability; however, warm ischemia-reperfusion injury raises concerns about graft quality. Mechanical postconditioning (MPC) may limit injury, but mechanisms remain incompletely characterized. Therefore, we investigated the roles of glucose metabolism and key signaling molecules in MPC using an isolated rat heart model of DCD. Hearts underwent 20 minutes perfusion, 30 minutes global ischemia, and 60 minutes reperfusion with or without MPC (two cycles: 30 seconds reperfusion-30 seconds ischemia). Despite identical perfusion conditions, MPC either significantly decreased (low recovery = LoR; 32 ± 5%; p < 0.05), or increased (high recovery = HiR; 59 ± 7%; p < 0.05) the recovery of left ventricular work compared with no MPC (47 ± 9%). Glucose uptake and glycolysis were increased in HiR vs. LoR hearts ( p < 0.05), but glucose oxidation was unchanged. Furthermore, in HiR vs. LoR hearts, phosphorylation of raptor, a downstream target of AMPK, increased ( p < 0.05), cytochrome c release ( p < 0.05) decreased, and TNFα content tended to decrease. Increased glucose uptake and glycolysis, lower mitochondrial damage, and a trend towards decreased pro-inflammatory cytokines occurred specifically in HiR vs. LoR MPC hearts, which may result from greater AMPK activation. Thus, we identify endogenous cellular mechanisms that occur specifically with cardioprotective MPC, which could be elicited in the development of effective reperfusion strategies for DCD cardiac grafts.
Competing Interests: The authors declare no conflict of interest.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies